GelMA Hydrogel Loading circNEFM-Engineered Exosomes Inhibits Glioma Growth
ACS Biomaterials Science & Engineering · 2025
DOI: 10.1021/acsbiomaterials.5c00998 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2025. Verfasst von Songning Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China. Hauptthemen laut MEDLINE: Exosomes, Glioma, RNA, Circular, Hydrogels. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
Glioma is a highly malignant tumor of the central nervous system characterized by high morbidity, substantial drug resistance, and poor prognosis. Therapeutic challenges stem from the invasive growth of tumor cells, limited drug penetration through the blood-brain barrier (BBB), and widespread drug resistance induced by the tumor microenvironment. In recent years, biotherapeutic strategies based on the biological characteristics of circular RNAs (circRNAs) have emerged as promising avenues for glioma management. circNEFM functions as a competitive endogenous RNA (ceRNA) by sponging miR-1248 and miR-1236, thereby upregulating the expression of BCL6B and C1orf115. This molecular mechanism of circNEFM effectively inhibits tumor proliferation while sensitizing glioma cells to chemotherapy. However, conventional delivery systems have inherent limitations, including short systemic circulation time and inadequate local drug concentration. To overcome these challenges, in this study, we engineered a multifunctional GelMA hydrogel scaffold system that integrates three key advantages: the innate ability of exosomes to traverse the BBB while protecting their cargo from enzymatic degradation, aptamer-mediated precise tumor targeting, and the sustained release profile of GelMA hydrogels. This composite scaffold exhibited excellent biomechanical properties and enabled the controlled release of engineered exosomes loaded with circNEFM (exo-circNEFM). Notably, aptamer-functionalized exosomes exhibited enhanced specificity to glioma cells, leading to significant inhibition of cell proliferation through circNEFM-mediated pathways and effective reversal of chemoresistance. This innovative therapeutic platform represents a novel technological solution with considerable translational potential for glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
- Department of Spine Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China.
- Department of Stomatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
- Medical Research Center, The Second Hospital of Jilin University, Changchun, Jilin 130041, China.
ORCID-Profile: Songning Fu
Förderung
- Department of Science and Technology of Jilin Province
Zitieren
APA
Fu, S., Tian, Z., Liu, L., Zhou, Z., Liu, T., Yang, Q., & Wang, Y. (2025). GelMA Hydrogel Loading circNEFM-Engineered Exosomes Inhibits Glioma Growth. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c00998
Vancouver
Fu S, Tian Z, Liu L, Zhou Z, Liu T, Yang Q, et al. GelMA Hydrogel Loading circNEFM-Engineered Exosomes Inhibits Glioma Growth. ACS Biomaterials Science & Engineering. 2025. doi:10.1021/acsbiomaterials.5c00998
BibTeX
@article{Fu2025,
author = {Fu, Songning and Tian, Zhisen and Liu, Lu and Zhou, Zongyi and Liu, Tianyu and Yang, Qiwei and Wang, Yuanyi},
title = {GelMA Hydrogel Loading circNEFM-Engineered Exosomes Inhibits Glioma Growth},
journal = {ACS Biomaterials Science & Engineering},
year = {2025},
doi = {10.1021/acsbiomaterials.5c00998}
}
EUVIMED